Responses
Poster Presentations
In-Progress clinical trials
P858 An open-label, multi-center trial of INO-5401 and INO-9012 delivered by electroporation (EP) in combination with cemiplimab in subjects with newly-diagnosed glioblastoma (GBM)
Compose a Response to This Article
Other responses
No responses have been published for this article.